Liminatus Pharma, Inc. (LIMN) stock
LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$2.81−0.16 (-5.39%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
Liminatus Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Liminatus Pharma's enterprise value was $162.98M on Nov 11, 2026, against $1.41B a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $162.98M | -80.3% |
| 2025 | Dec 31, 2025 | $826.19M | – |
See a number that looks wrong?